Report: Role of MEMS, Nanotechnology Growing in Diabetes Care
During the first half of 2006 there was a noticeable upswing in activity focused on the development of MEMS (microelectromechanical systems) and nanotechnology-based solutions for the care and management of diabetes, according to market research firm Bourne Research. The firm reports that a variety of MEMS devices, nanostructures and other emerging technologies are being tapped for blood glucose-monitoring and insulin delivery and for diabetes-related complications, including those related to the eyes and gastrointestinal tract. Even though a few large firms dominate the diabetes market, it remains attractive for startups with innovative ideas, and five companies have received nearly $80 million in venture capital funding in the past few months, the firm said. Scottsdale, Ariz.-based Bourne Research's Bourne Report analyses emerging technologies, with a focus on MEMS and nanotechnology. More details about the diabetes report can be found in The Bourne Report Medical Device Quarterly. To subscribe or for more information, visit: www.bourneresearch.com
- The use of atoms, molecules and molecular-scale structures to enhance existing technology and develop new materials and devices. The goal of this technology is to manipulate atomic and molecular particles to create devices that are thousands of times smaller and faster than those of the current microtechnologies.
MORE FROM PHOTONICS MEDIA